VELscope system honored by the WHO

Source: Dentistry IQ Author: Staff Jul 7, 2010 BURNABY, British Columbia—LED Dental has announced that the World Health Organization has recognized the VELscope enhanced oral assessment system as an innovative device that addresses global health concerns. In 2009, the WHO Department of Essential Health Technologies challenged the scientific and business communities to identify and develop innovative technologies to address global health concerns. On June 30, following months of evaluation, the organization officially recognized those innovative medical devices--either existing or under development--that address global health concerns and which are likely to be accessible, appropriate and affordable for use in low- and middle-income countries. The VELscope system was one of only eight commercialized devices so honored. “It is extremely gratifying to receive this prestigious honor,” said Peter Whitehead, founder and CEO of LED Dental and inventor of the VELscope system. “We created the VELscope system to improve the oral health of patients worldwide by helping dental practitioners discover everything from early-stage oral cancer to any number of more common oral abnormalities. This recognition from the World Health Organization is further reinforcement of what thousands of VELscope users have been telling us: that the VELscope system can help improve oral health in a very cost-effective and userfriendly manner.” Oral cancer kills one American every hour of every day. According to the SEER data base, oral cancer has a higher mortality rate than several better publicized cancers, such as cervical cancer and testicular cancer. Some oral cancers are now known to be linked to [...]

2010-07-08T13:14:47-07:00July, 2010|Oral Cancer News|

Fruit and vegetables only modestly linked to reduced cancer risk, large study questions conventional wisdom

Source: www.medicalnewstoday.com Author: Catharine Paddock, PhD A large study of over 400,000 people living in ten western European countries found only a modest link between high intake of fruit and vegetables and reduction in overall cancer risk: thus failing to confirm the widely held belief enshrined in the World Health Organization's recommendation that people should eat five servings of fruit and vegetables a day to prevent cancer and other diseases. Dr Paolo Boffetta, of the Mount Sinai School of Medicine in New York, and colleagues, wrote about their findings in a study published in the 6 April online issue of the Journal of the National Cancer Institute. In 1990 the World Health Organization recommended people eat five helpings of fruit and vegetables a day to reduce their risk of cancer, cardiovascular and other diseases. But since then, many studies have either produced inconsistent results or failed to find a significant link between fruit and vegetable intake and cancer risk, wrote the authors. For their prospective study, Boffetta and colleagues analyzed data from the European Prospective Investigation into Cancer and Nutrition (EPIC), which recruited 142,605 men and 335,873 women in Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden and the United Kingdom, between 1992 and 2000. The data were mostly self-reported by the participants and detailed their dietary and lifestyle habits. The participants were followed for a median of 8.7 years, during which time deaths and incidents of cancer diagnoses were noted. The researchers then analysed the data using [...]

Visual Screening for Oral Cancer is Cost Effective in Low-Income Countries

Source: Carolina News Wire Writer: Lisa Bistreich, Patrick Gibbons RESEARCH TRIANGLE PARK, N.C. — Using visual inspection to screen for oral cancer is a cost-effective approach to earlier diagnosis in low- and middle-income countries, according to a study conducted by researchers at RTI International.  The study, published in the Bulletin of the World Health Organization, looked at health care workers in Southern India, where oral cancer is a major health problem, and found that visual oral screening, particularly among high-risk individuals is cost-effective. "Our results show that screening for oral cancers by visual inspection is comparable or less expensive than the more widely accepted practice of screening for cervical cancers," said lead author Sujha Subramanian, a senior health economist at RTI. "We hope that the findings of this study will increase screening for oral cancers and help reduce the devastating impact of this cancer on families." More than 160,000 people participated in the study, and the researchers found that targeted screening of the high-risk group of alcohol and tobacco users is the most cost-effective approach. They determined that visual inspection for oral cancer targeted to high-risk people could be performed for under $6 per person over the course of a nine-year screening program.  According to GLOBOCAN, the Indian subcontinent alone accounts for one-third of the world burden and oral cancer is the most common form of cancer and cancer-related death among men in India. Two-thirds of all deaths from oral cancers occur in low income countries. Worldwide, 270,000 new cases and 145,000 [...]

2009-02-12T16:14:33-07:00February, 2009|Oral Cancer News|

Diagnostic aids in the screening of oral cancer

Source: 7thspace.com Author: Stefano Fedele The World Health Organization has clearly indentified prevention and early detection as major objectives in the control of the oral cancer burden worldwide. At the present time, screening of oral cancer and its pre-invasive intra-epithelial stages, as well as its early detection, is still largely based on visual examination of the mouth. There is strong available evidence to suggest that visual inspection of the oral mucosa is effective in reducing mortality from oral cancer in individuals exposed to risk factors. Simple visual examination, however, is well known to be limited by subjective interpretation and by the potential, albeit rare, occurrence of dysplasia and early OSCC within areas of normal-looking oral mucosa. As a consequence, adjunctive techniques have been suggested to increase our ability to differentiate between benign abnormalities and dysplastic/malignant changes as well as to identify areas of dysplasia/early OSCC that are not visible to naked eye. These include the use of toluidine blue, brush biopsy, chemiluminescence and tissue autofluorescence. The present paper reviews the evidence supporting the efficacy of the aforementioned techniques in improving the identification of dysplastic/malignant changes of the oral mucosa. We conclude that available studies have shown promising results, but strong evidence to support the use of oral cancer diagnostic aids is still lacking. Further research with clear objectives, well-defined population cohorts, and sound methodology is strongly required. Source: Head &Neck Oncology 2009, 1:5

Go to Top